NFSG

Newbridge Financial Services Group Portfolio holdings

AUM $616M
1-Year Return 28.58%
This Quarter Return
-5.05%
1 Year Return
+28.58%
3 Year Return
+132.16%
5 Year Return
+230.4%
10 Year Return
AUM
$203M
AUM Growth
-$8.32M
Cap. Flow
+$8.89M
Cap. Flow %
4.37%
Top 10 Hldgs %
28.96%
Holding
1,616
New
155
Increased
428
Reduced
295
Closed
124

Sector Composition

1 Technology 28.74%
2 Consumer Discretionary 13.72%
3 Communication Services 6.59%
4 Financials 6.4%
5 Healthcare 6.09%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
RPAY icon
1351
Repay Holdings
RPAY
$506M
$1K ﹤0.01%
50
RSPT icon
1352
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$3.77B
$1K ﹤0.01%
+50
New +$1K
LKQ icon
1353
LKQ Corp
LKQ
$8.33B
$1K ﹤0.01%
20
AAP icon
1354
Advance Auto Parts
AAP
$3.63B
$1K ﹤0.01%
5
-10
-67% -$2K
AFG icon
1355
American Financial Group
AFG
$11.6B
$1K ﹤0.01%
+10
New +$1K
AJG icon
1356
Arthur J. Gallagher & Co
AJG
$76.7B
$1K ﹤0.01%
7
AKRO icon
1357
Akero Therapeutics
AKRO
$3.58B
$1K ﹤0.01%
65
ALL icon
1358
Allstate
ALL
$53.1B
$1K ﹤0.01%
10
+3
+43% +$300
AUUDW
1359
Auddia Inc Warrants
AUUDW
$68.6K
$1K ﹤0.01%
1,500
BDC icon
1360
Belden
BDC
$5.14B
$1K ﹤0.01%
27
BTBT icon
1361
Bit Digital
BTBT
$807M
$1K ﹤0.01%
200
CDE icon
1362
Coeur Mining
CDE
$9.43B
$1K ﹤0.01%
229
+199
+663% +$869
CME icon
1363
CME Group
CME
$94.4B
$1K ﹤0.01%
5
COGT icon
1364
Cogent Biosciences
COGT
$1.82B
$1K ﹤0.01%
122
COLL icon
1365
Collegium Pharmaceutical
COLL
$1.21B
$1K ﹤0.01%
64
CPT icon
1366
Camden Property Trust
CPT
$11.9B
$1K ﹤0.01%
8
-1
-11% -$125
CRGY icon
1367
Crescent Energy
CRGY
$2.23B
$1K ﹤0.01%
60
CTVA icon
1368
Corteva
CTVA
$49.1B
$1K ﹤0.01%
21
-5
-19% -$238
CVE icon
1369
Cenovus Energy
CVE
$28.7B
$1K ﹤0.01%
37
CWB icon
1370
SPDR Bloomberg Convertible Securities ETF
CWB
$4.42B
$1K ﹤0.01%
15
DADA
1371
DELISTED
Dada Nexus
DADA
$1K ﹤0.01%
100
DINO icon
1372
HF Sinclair
DINO
$9.56B
$1K ﹤0.01%
20
DOV icon
1373
Dover
DOV
$24.4B
$1K ﹤0.01%
4
EVR icon
1374
Evercore
EVR
$12.3B
$1K ﹤0.01%
12
FATE icon
1375
Fate Therapeutics
FATE
$116M
$1K ﹤0.01%
16